A Phase 2, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Alixorexton (ALKS 2680) in Patients With Idiopathic Hypersomnia: Study Design and Methods for Vibrance-3

Sleep Medicine 2026

View at publisher

Authors: D. Plante, R. Grunstein, Giuseppe Plazzi, Kiran Prasad Maski, J. Ramos, Y. Du, Alexandra Lovett, M. Yountz, Bhaskar Rege

DOI: 10.1016/j.sleep.2025.107490

Cited by: 0

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and related disorders Obstructive Sleep Apnea Research